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Abstract:  
A series  of N-(4-(benzyloxy)benzylidene)-2-(arylimino)-6-(phenylimino)-3,6-dihydro-2H-1,3,5-thiadiazin-4-
amine derivatives (4a-d) have  been  synthesized  by  condensation of 1-(N-4-(benzyloxy) 
benzylidenecarbamimidoyl)-3-arylthiourea (3a-d) with phenyl isocyanodichloride. Interaction of 1-
carbamimidoyl-3-arylthiourea (2a-d) and p-benzyloxy benzaldehyde yielded (3a-d).  Monoacetyl (5b) and 
mononitroso (6b) derivatives were also synthesised by substitution of hydrogen atom of cyclic –NH- of 4b on 
treatment with acetic anhydride and sodium nitrite respectively. Further, 4b upon boiling with  5% aqueous 
ethanolic (1:1) sodium  hydroxide  solution underwent isomerisation into corresponding 4-(4-
(benzyloxy)benzylideneamino)-6-(4-chlorophenylimino)-1-phenyl-5,6-dihydro-1,3,5-triazine-2(1H)-thione (7b). 
The structures of the newly synthesized 1,3,5-thiadiazine derivatives have been established on the basis of 
chemical transformations, elemental analysis and IR, 1H NMR, and Mass spectral studies. The zone of inhibition 
for some of the title compounds synthesized were determined against E. coli, S. aureus, B. thurengienesis and E. 
aerogenes and compared with Chloramphenicol as a reference drug. Some of the newly synthesized compounds 
showed moderate to high antimicrobial activity. Antioxidant activities of all the compounds were also 
determined. 4a, 4c and 4d were found to possess significant antioxidant activity. 
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INTRODUCTION:  
A large number of organic compounds containing 
nitrogen or sulphur or both are known to possess 
antimicrobial activity. Thiadiazine is a six 
membered heterocyclic compound containing two 
nitrogen atoms and one sulphur atom in alternate 
position. Different synthetic routes are available in 
the literature (1-7) which focuses on its synthesis. 
Novel heterocycles like 1,3,5-thiadiazines 
possessing wide spectrum biological activities that 
have stimulated considerable research work in last 
few decades leading to the synthetic utility of the 
derivatives of this ring system. 1,3,5-thiadiazines 
have been shown to possess various 
pharmacological activities such as antimicrobial (8-
11), antifungal (12-13), herbicidal, nematocidal 
(14), antiprotozoal (15), tuberculostatic (16-17) and 
anticancer (18). The tetrahydro-2H-1,3,5-
thiadiazine-2-thione (THTT) scaffold has been 
used for arteriosclerosis treatment (19) while its 
application in antiepileptic pro-drugs has been 
reported recently (20). In our search for new 
potential antimicrobial compounds, the reaction of 
N-phenyl isocyanodichloride and 1-(N-4-
(benzyloxy) benzylidenecarbamimidoyl)-3-aryl 
thiourea to yield a series of 1,3,5-thiadiazin-4-
amines was found to be interesting.  This 
stimulated us to synthesize some novel 1,3,5-
thiadiazine derivatives and considering the 
structural features, it was thought to carry out the 
biological screening and the compounds reported in 
this communication have been also tested for their 
antioxidant activity.                              
 
MATERIAL AND METHODS: 
Chemicals used for the synthesis were of AR grade 
of Merck, S.D.Fine and Aldrich. The melting 
points were recorded in open capillary in paraffin 
bath and are uncorrected. IR spectra were recorded 
on a Shimadzu IR Spectrophotometer (KBr, v max 
in cm-1). Positive-ion Electro Spray Ionization 
(ESI) mass spectra were obtained with a Waters 
Micromass Q–TOF Micro, Mass 
Spectrophotometer. 1H NMR spectra are recorded 
on a Bruker AM 400 instrument (400 MHz) using 
tetramethylsilane (TMS) as an internal reference 
and DMSO-d6 as solvent. Chemical Shifts are 
given in parts per million (ppm). Elemental (CHN) 
analysis was done using Thermo Scientific (Flash-
2000), the compounds were analyzed for carbon, 
hydrogen and nitrogen and the results obtained are 
in good agreement with the calculated values. The 
reactions were monitored by E. Merck TLC 
aluminum sheet silica gel 60 F254 and visualizing 
the spot in UV Cabinet and iodine chamber.  
Experimental 
The preparation of starting material such as p-
benzyloxy benzaldehyde, aryl isothiocyanate 
(RNCS) and aryl isocynodichloride were carried 
out according to the schemes (1-3) following the 
procedure as per the literature (21). 
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Procedure for synthesis of 1-carbamimidoyl-3-phenylthiourea (2a):  In a clean dry round-bottomed flask 
containing mixture of guanidine nitrate (10 mmol) and phenyl isothiocyanate (1a, 10 mmol) in alcohol (25 mL) 
sodium hydroxide (10 mmol) was added. The reaction mixture was refluxed for 2h and poured into crushed ice, 
filtered, dried and recrystallized from ethanol to give 2a (Scheme 4). Similarly, 2b-d were synthesised from 1b-
d by extending the same procedure followed for 2a.  
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1-carbamimidoyl-3-phenylthiourea (2a): White 
crystalline solid, mp: 170-172°C yield: 78.0%, M. 
F. C8H10SN4, Recrystallizing solvent: Ethanol, 1-
carbamimidoyl-3-(4-chlorophenyl)thiourea (2b): 
White crystalline solid, mp: 178-180°C yield: 
84.0%, M. F.  C8H9N4SCl, Recrystallizing solvent: 
Ethanol, 1-carbamimidoyl-3-(4-methylphenyl) 
thiourea (2c): White crystalline solid, mp: 190-
192°C yield: 82.0%, M. F.  C9H12N4S, 
Recrystallizing solvent: acetic acid, 1-carbami 
midoyl-3-(2-methylphenyl)thiourea (2d): White 
crystalline solid, mp: 164-166°C yield: 81.0%, M. 
F.  C8H10N4S, Recrystallizing solvent: Ethanol. 
 
Procedure for synthesis of 1-(N-4-(benzyloxy) 
benzylidenecarbamimidoyl)-3-phenyl thiourea 
(3a):  To a mixture of 1-carbamimidoyl-3-
phenylthiourea (10 mmol), p-benzyloxy 
benzaldehyde (10 mmol) in ethanol (30 mL), few 
drops of glacial acetic acid  were added and was 
refluxed for 2h.  It was then cooled poured into 
crushed ice, filtered, dried and recrystallized from 
ethanol to afford 3a (Scheme 5). Similarly, 3b-d 
were synthesised from 2b-d by adopting the same 
procedure followed for 3a. 
1-(N-4-(benzyloxy)benzylidenecarbamimidoyl)-
3-phenylthiourea (3a): Pale yellow crystals, mp: 
90-92°C yield: 76.0%, M. F. C22H18N3S, Rf: 0.88, 
Recrystallizing solvent: Ethanol, 1-(N-4-
(benzyloxy)benzylidenecarbamimidoyl)-3-(4-
chlorophenyl)thiourea (3b): Pale yellow crystals, 
mp: 107-109°C yield: 82.0%, M. F. C22H18N3S, Rf: 
0.94, Recrystallizing solvent: Ethanol, 1-(N-4-
(benzyloxy)benzylidenecarbamimidoyl)-3-p-
tolylthiourea (3c): Pale yellow crystals, mp: 160-
162°C yield: 84.0%, M. F. C23H20N3S, Rf : 0.91, 
Recrystallizing solvent: Methanol. 1-(N-4-
(benzyloxy)benzylidenecarbamimidoyl)-3-o-tolyl 
thiourea (3d): Pale yellow crystals, mp: 120-
122°C yield: 82.0%, M. F. C23H20 N3S, Rf : 0.85, 
Recrystallizing solvent: Ethanol. 
 
Procedure for preparation of N-(4-(benzyloxy) 
benzylidene)-2,6-bis(phenylimino)-3,6-dihydro-
2H-1,3,5-thiadiazin-4-amine (4a):  3a (10 mmol) 
and phenyl isocyanodichloride (10 mmol) were 
refluxed in chloroform (25 mL) for 2h over a water 
bath.  The reaction mixture was allowed to 
evaporate the solvent and kept overnight; the sticky 
mass so obtained was washed with petroleum ether 
followed by alcohol. The reaction mixture was 
neutralized by adding ammonium hydroxide. The 
precipitate so obtained was washed, dried and 
recrystallized from ethanol to afford 4a. Similarly, 
4b-d were synthesised from 3b-d following the 
same procedure as for 4a (Scheme 6). 
N-(4-(benzyloxy)benzylidene)-2,6-bis(phenyl 
imino)-3,6-dihydro-2H-1,3,5-thiadiazin-4-amine 
(4a): Pale yellow crystals, mp: 96-99°C yield: 
84.0%, M. F. C29H23N5OS, Rf : 0.94, IR: 3411 (NH 
str.),3033 (ArH str.), 2906, 2864 (-CH2- str.), 1624, 
1605, 1590, 1573 (C=N str.), 1251, 1011 (C-O-C 
asym.), 1573, 1508, 1484 (C=C), 1106, 1164 (C-
N), 694 (C-S-C), 908, 880, 821 (C-S str.) 1H 
NMR: 5.19 (s, 2H, Ph-CH2O-), 4.8-5.0 (br., 1H, C-
NH-C), 8.50 (s, 1H, N=CH), 6.54-7.89 (m, 19H, 
ArH) MS: m/z 489 M+, 512 [(M+Na)+], 490 
[(M+H)+], Calculated: C, 71.16, H, 4.70, N, 14.31 
Found: C, 78.12, H, 5.63, N, 5.50 
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N-(4-(benzyloxy)benzylidene)-2-(4-chlorophenyl 
imino)-6-(phenylimino)-3,6-dihydro-2H-1,3,5-
thiadiazin-4-amine (4b): Pale yellow crystals, mp: 
66-68°C yield: 82.0%, M. F. C29H22N5OSCl, Rf : 
0.87, Recrystallizing solvent: Ethanol. N-(4-
(benzyloxy)benzylidene)-6-(phenylimino)-2-(p-
tolylimino)-3,6-dihydro-2H-1,3,5-thiadiazin-4-
amine (4c): Pale yellow crystals, mp: 164-166°C 
yield: 85.0%, M. F. C30H25N5OS, Rf : 0.90, 
Recrystallizing solvent: Ethanol. N-(4-
(benzyloxy)benzylidene)-6-(phenylimino)-2-(o-
tolylimino)-3,6-dihydro-2H-1,3,5-thiadiazin-4-
amine (4d): Pale yellow crystals, mp: 168-170°C 
yield: 87.0%, M. F. C30H25N5OS, Rf : 0.87, 
Recrystallizing solvent: Ethanol. 
 
Procedure for the synthesis of 1-(4-(4-
(benzyloxy)benzylideneamino)-2-(4-chloro 
phenylimino)-6-(phenylimino)-2H-1,3,5-
thiadiazin-3(6H)-yl)ethanone (5b): A mixture of 
acetic anhydride (10 mmol), glacial acetic acid (10 
mL) and 4b (10 mmol) were refluxed for 2h. Then 
the reaction mixture was poured in crushed ice and 
separated product was filtered and recrystallized 
from ethanol to yield 5b (Scheme 7).  
Physical data: Colour: Pale yellow crystals, mp: 
75-77°C yield: 73.0%, M. F. C31H24N5OSCl, Rf : 
0.74.  
 
Procedure for the synthesis of N-(4-(benzyloxy) 
benzylidene)-2-(4-chlorophenylimino)-3-nitroso-
6-(phenylimino)-3,6-dihydro-2H-1,3,5-thiadiazin 
-4-amine (6b): A  mixture of ethanol (10 mL) and 
4b (10 mmol) was cooled below 5°C.  Sodium 
nitrite solution (10 mmol) in water (2mL) was 
added to this cold solution drop wise with stirring, 
yellowish solid so obtained was filtered and 
recrystallized from ethanol (Scheme 8). Physical 
data: Colour: Pale yellow crystals, mp: 76-79°C 
yield: 68.0%, M. F. C29H21ClN6O2S, Rf: 0.76. 
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Procedure for the synthesis of 4-(4-(benzyloxy) 
benzylideneamino)-6-(4-chlorophenylimino)-1-
phenyl-5,6-dihydro-1,3,5-triazine-2(1H)-thione 
(7b): A mixture of 5% ethanolic sodium hydroxide 
solution (1:1) and 4b (10mmol) was boiled in a 
round bottom flask for 1.5h.  The reaction mixture 
was cooled and the product obtained was filtered 
and recrystallized from ethanol to get 7b (Scheme 
9). Physical data: Colour: Brown solid, mp: 78-
82°C yield: 65.0%, M. F. C23H17ClN5OS, Rf: 0.84. 
 
Antibacterial Activity:  
The novel synthesized heterocyclic compounds 
were screened for their in vitro antimicrobial 
activity using cup plate agar disc-diffusion method 
against two Gram positive bacterial strains, B. 
thurengienesis and S. aureus and two Gram 
negative strains, E. coli and E. aerogenes. 
Chloramphenicol was used as standard drugs for 
bacteria.  
Procedure for the determination of Zone of 
Inhibition by Agar disc-diffusion method:  
Test solutions were prepared with known weight of 
compound in dimethyl sulphoxide (DMSO) and 
diluted suitably to give the resultant concentration 
of 31, 62, 125, 250, 500 and 1000µg/mL. 
Whatmann no. 1 sterile filter paper discs (6 mm) 
were impregnated with solution and allowed to dry 
at room temperature. In vitro antibacterial activity 
was determined by using Mueller Hinton Agar 
obtained from Himedia Ltd., Mumbai. Twenty-four 
hours old culture of selected bacterial strain was 
mixed with physiological saline and the turbidity 
was corrected by adding sterile physiological saline 
and sub cultured on Sabouraud Dextrose and 
suspended in sterile distilled water to an 
absorbance of 0.6 at 450 nm. Petri plates were 
prepared by pouring 10 ml of Mueller Hinton Agar 
for bacteria containing microbial culture was 
allowed to solidify. The discs were then applied 
and the plates were incubated at 37°C for 24h 
(bacteria) and the inhibition zone was measured as 
diameter in four directions and expressed as mean. 
The results were compared using Chloramphenicol 
as a standard antibacterial agent. The results of 
antibacterial activity (i.e. Zone of inhibition in mm) 
of the synthesized compounds are given in the 
Table 1-8.  
Antioxidant Activity: The reducing power in-vitro 
model was used to evaluate antioxidant activity 
according to the method of Oyaizu (22). This 
method is based on the principle of increase in the 
absorbance of the reaction mixture, indicates 
increase in the antioxidant activity hence increasing 
reducing power of the samples. In this method 
antioxidant compound gives a colored complex 
with potassium ferricyanide, trichloroacetic acid 
and ferric chloride, which is measured at 700 nm. 
Procedure: The standard drug and test compounds 
were dissolved in dimethyl formamide so as to get 
different concentrations (20μg/mL to 100μg/mL). 
This was mixed with 2.5mL of (pH 6.6) 0.2 mol 
phosphate buffer and 2.5mL of 1 % potassium 
ferricyanide. The mixture was incubated at 50°C 
for 20 minutes. 2.5mL of 10 % trichloroacetic acid 
was added to the mixture, which was then 
centrifuged for 10 minutes at 1000 rpm. 2.5mL 
upper layer of solution was mixed with 2.5mL of 
distilled water and 0.5mL of 0.1% ferric chloride. 
The absorbance was measured at 700nm. The 
absorbance of the blank was also measured in 
similar manner. The results were compared with 
ascorbic acid, which was used as a reference 
standard antioxidant. Antioxidant activities of some 
representative compounds are given in Table 9. 
 
RESULT AND DISCUSSIONS:  
The targeted products 2-7 have been synthesized by 
common pathway as summarized in reaction 
scheme 1-7. The reactions were monitored by TLC. 
The identities of the newly synthesized compounds 
have been established on the basis of their general 
chemical investigation, elemental analysis and 
spectral data such as IR, 1H NMR and Mass 
spectral studies (23).  
Reaction of RNCS (aryl isothiocyanate, 1a-d) with 
1-carbamimidoyl-3-arylthiourea (2a-d) afforded 1-
(N-4-(benzyloxy) benzylidenecarbamimidoyl)-3-
arylthiourea (3a-d). Reaction of 3a-d with one 
equivalent of phenyl isocyanodichloride in 
refluxing chloroform yielded respective 1,3,5-
thiadiazines 4a-d.   The IR spectra of 4a exhibited 
characteristic band at 3411 cm-1 (broad) for free 
and bonded N-H. The peak at 1251 cm-1 was 
assigned to C-O-C, the peak at 1624 cm-1 was 
assigned to C=N, a peak at 694 and 908, 880, 821 
cm-1 is due to C-S-C and C-S stretch, in association 
of these peaks other bands due C-H and C=C 
stretch in aromatic region appeared in accordance 
with the literature. Further support for 4a came 
from the 1H NMR spectrum which exhibited singlet 
and a broad peak at 5.19 ppm and 4.8-5.0 ppm 
which integrated for two proton and one proton 
were designated to the -CH2- of  Ph-CH2-O- group 
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and –NH protons respectively, other signals 
associated with aromatic protons were obtained as  
multiplet in the range of δ 6.54 to 7.89 ppm due to 
nineteen  protons confirms the formation of 4a 
which was also confirmed by mass spectrum with a 
molecular ion peak at m/z 489 [(M +Na)+, 512] is 
in agreement with the molecular formula 
C29H23N5OS (Scheme 6). Elemental analysis 
revealed that the expected percentage of elements 
such as carbon, hydrogen and nitrogen in 4a. 
Extending the reactions of (4b), on  acylation it 
yielded monoacetyl derivative  (5b), while its 
reaction  with  sodium  nitrite  in  acidic  medium  
yielded mononitroso derivative (6b), and on 
boiling with 5% aqueous ethanolic (1:1) sodium  
hydroxide  solution  isomerizes into 
corresponding 1-phenyl-2-phenylimino-4-
(substituted)-benzylidene amino-6-thio-1,3,5-
triazine (7b).   
Antimicrobial activity:  
All the synthesized substituted 1, 3, 5-thiadiazines 
(4a-d) and derivatives 5b, 6b and 7b were screened 
for antimicrobial activity.  Table no. 2-8 shows the 
inhibition zone determined in mm for title 
compounds at different concentrations from 31-
1000 µg/mL using Chloramphenicol as the 
standard drug (Table 1). Data obtained revealed 
that the test compound (4a-d) showed to possess 
moderate to high activity and derivatives 5b, 6b, 
7b possess least antimicrobial activity when 
compared with standard drug; however in some 
cases it was better than Chloramphenicol. 4a-d are 
highly active against E. areogenes and S. aureus at 
the almost all concentration and moderately active 
against E. coli whereas inactive against B. 
thurengienesis. The results were found to be 
excellent at 31 µg/mL concentrations.  
Antibacterial activity: Zone of Inhibition in mm 
Table 1:  For Chloramphenicol (Standard) 
Sr. 
No. 
Concentration of 
Solution 
In µg/ml  
E. coli 
 (Gm-ve) 
E. aerogenes  
(Gm-ve) 
S. aureus 
 (Gm+ve) 
B. thurengienesis 
 (Gm+ve) 
1 1000 29 19 27 30 
2 500 20 16 30 20 
3 250 18 17 27 21 
4 125 17 16 21 16 
5 62.2 11 15 20 16 
6 31.125 12 11 11 15 
 
Table 2:  For N-(4-(benzyloxy)benzylidene)-2,6-bis(phenylimino)-3,6-dihydro-2H-1,3,5-thiadiazin-4-
amine (4a) 
Sr. 
No. 
Concentration 
of Solution 
In µg/ml 
E. coli 
 (Gm-ve) 
E. aerogenes 
 (Gm-ve) 
S. aureus 
 (Gm+ve) 
B. thurengienesis 
 (Gm+ve) 
1 1000 19 18 35 17 
2 500 13 20 32 26 
3 250 15 18 30 20 
4 125 11 - 28 22 
5 62.2 14 - 26 11 
6 31.125 14 19 24 16 
 
Table 3: For N-(4-(benzyloxy)benzylidene)-2-(4-chlorophenylimino)-6-(phenylimino)-3,6-dihydro-2H-
1,3,5-thiadiazin-4-amine (4b) 
Sr. 
No. 
Concentration 
of Solution 
In µg/ml  
E. coli 
 (Gm-ve) 
E. aerogenes 
 (Gm-ve) 
S. aureus 
 (Gm+ve) 
B. thurengienesis 
(Gm+ve) 
1 1000 19 18 34 17 
2 500 13 20 30 26 
3 250 15 18 - 
 
20 
4 125 11 - - 
 
22 
5 62.2 14 - - 
 
11 
6 31.125 14 19 20 16 
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Table 4: For N-(4-(benzyloxy)benzylidene)-6-(phenylimino)-2-(p-tolylimino)-3,6-dihydro-2H-1,3,5-
thiadiazin-4-amine (4c) 
Sr. 
No. 
Concentration 
of Solution 
In µg/ml  
E. coli 
 (Gm-ve) 
E. aerogenes 
 (Gm-ve) 
S. aureus 
 (Gm+ve) 
B. thurengienesis 
(Gm+ve) 
1 1000 19 18 37 17 
2 500 13 20 32 26 
3 250 15 18 
 
 
- 
 
20 
4 125 11 - - 
 
22 
5 62.2 14 - - 
 
11 
6 31.125 14 12 18 16 
 
Table 5: For N-(4-(benzyloxy)benzylidene)-6-(phenylimino)-2-(o-tolylimino)-3,6-dihydro-2H-1,3,5-
thiadiazin-4-amine (4d) 
Sr. 
No. 
Concentration 
of Solution 
In µg/ml  
E. coli 
 (Gm-ve) 
E. aerogenes 
 (Gm-ve) 
S. aureus 
 (Gm+ve) 
B. thurengienesis 
 (Gm+ve) 
      
1 1000 19 18 37 17 
2 500 13 20 34 26 
3 250 15 18 - 
 
20 
4 125 11 - - 
 
22 
5 62.2 14 - - 
 
11 
6 31.125 14 13 18 16 
 
Table 6: For 1-(4-(4-(benzyloxy)benzylideneamino)-2-(4-chlorophenylimino)-6-(phenylimino)-2H-1,3,5-
thiadiazin-3(6H)-yl)ethanone (5b): 
Sr. 
No. 
Concentration 
of Solution 
In µg/ml  
E. coli 
 (Gm-ve) 
E. aerogenes 
 (Gm-ve) 
S. aureus 
 (Gm+ve) 
B. thurengienesis 
 (Gm+ve) 
      1 1000 - 11 10 8 
2 500 8 10 8 11 
3 250 - 15 7 10 
4 125 - - 7 7 
5 62.2 7 7 - 7 
6 31.125 6 6 - 9 
 
Table 7: For N-(4-(benzyloxy)benzylidene)-2-(4-chlorophenylimino)-3-nitroso-6-(phenylimino)-3,6-
dihydro-2H-1,3,5-thiadiazin-4-amine (6b) 
Sr. 
No. 
Concentration 
of Solution 
In µg/ml  
E. coli 
 (Gm-ve) 
E. aerogenes 
 (Gm-ve) 
S. aureus 
 (Gm+ve) 
B. thurengienesis 
 (Gm+ve) 
1 1000 - 12 20 
 
8 
2 500 8 11 8 9 
3 250 - 15 6 10 
4 125 7 - 12 9 
5 62.2 - - 11 14 
6 31.125 5 14 10 
 
12 
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Table 8: For 4-(4-(benzyloxy)benzylideneamino)-6-(4-chlorophenylimino)-1-phenyl-5,6-dihydro-1,3,5-
triazine-2(1H)-thione (7b) 
Sr. 
No. 
Concentration 
of Solution 
In µg/ml  
E. coli 
 (Gm-ve) 
E. aerogenes 
 (Gm-ve) 
S. aureus 
 (Gm+ve) 
B. thurengienesis 
(Gm+ve) 
1 1000 - 13 22 
 
6 
2 500 7 12 6 10 
3 250 - 16 8 10 
4 125 8 - 10 11 
5 62.2 - - 9 12 
6 31.125 6 13 7 
 
10 
 
Table 9 : Antioxidant Activity of 4a-d and 5b-7b 
 
Compound 
Code 
Absorbance             %Increase in Absorbance 
20 
µg/mL 
40 
µg/mL 
60 
µg/mL 
80 
µg/mL 
100 
µg/mL 
20 
µg/mL 
40 
µg/mL 
60 
µg/mL 
80 
µg/mL 
100 
µg/mL 
Control 0.100 -- 
Standard 
(Ascorbic 
acid) 
0.148 0.157 0.162 0.176 0.183 48 57 62 76 83 
4a 0.106 0.110 0.150 0.167 0.178 6 10 50 67 94 
4b 0.115 0.124 0.133 0.148 0.159 15 24 33 48 59 
4c 0.142 0.160 0.173 0.181 0.183 42 60 73 81 83 
4d 0.143 0.158 0.164 0.179 0.182 43 58 64 79 82 
5b 0.153 0.157 0.170 0.175 0.179 53 57 70 75 79 
6b 0.152 0.155 0.160 0.170 0.189 52 55 60 70 89 
7b 0.135 0.147 0.168 0.179 0.181 35 47 68 79 81 
 
 
 
Fig 1: Reducing power of the synthesized compounds as compared with the standard Ascorbic Acid (AA) 
at concentrations from 20-100µg/ mL 
Antioxidant activity:  
All the synthesized compounds (4a-d) and its 
derivatives 5b, 6b and7b were assessed for their in 
vitro antioxidant activities using free radical 
reducing power at various concentrations. The 
results revealed that the tested compounds 4a, 4c 
and 4d possesses significant antioxidant activity 
while 4b, 5b, 6b, 7b gives mild antioxidant activity 
when compared to control (Figure 1). 
 
CONCLUSION: In conclusion, we have reported 
here the title compounds (4a-d) synthesized by 
condensation of 1-(N-4-(benzyloxy) benzylidene 
carbamimidoyl)-3-arylthiourea and phenyl 
isocyanodichloride were confirmed to be 1,3,5-
thiadiazine derivatives by spectral analysis. 
Antibacterial screening of all the synthesized 
compounds was done and found to possess 
moderate to good activity against selected strains of 
bacteria. The results were found to be excellent 
with solution having minimum concentration; 
moreover the prepared derivatives 5b and 6b and 
the isomer 7b were found to be inactive against all 
four bacterial strains. Antioxidant activity of the 
synthesized compounds also showed moderate to 
good activity. 
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